Bvf Partners L P/il
Visual SEC Form 4 history across 4 companies, 17 transactions and 4 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #52831 | XOMA | Bvf Partners L P/il | 10% | sale | 339k | -$886M | S | 01/28/2025 | 01/24/2025 |
| #32804 | OLMA | Bvf Partners L P/il | DIR | grant | 22.7k | — | A | 01/14/2025 | 01/10/2025 |
| #32803 | OLMA | Bvf Partners L P/il | DIR | grant | 161k | — | A | 01/14/2025 | 01/10/2025 |
| #32802 | OLMA | Bvf Partners L P/il | DIR | grant | 235k | — | A | 01/14/2025 | 01/10/2025 |
| #32801 | OLMA | Bvf Partners L P/il | DIR | return | 22.7k | — | D | 01/14/2025 | 01/10/2025 |
| #32800 | OLMA | Bvf Partners L P/il | DIR | return | 161k | — | D | 01/14/2025 | 01/10/2025 |
| #32799 | OLMA | Bvf Partners L P/il | DIR | return | 235k | — | D | 01/14/2025 | 01/10/2025 |
Bvf Partners L P/il Insider Activity FAQ
SEC Form 4 context
Who is Bvf Partners L P/il?
Bvf Partners L P/il is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001055947.
Which companies has Bvf Partners L P/il reported transactions for?
IMMUNIC, INC., Repare Therapeutics Inc., XOMA Royalty Corp, Olema Pharmaceuticals, Inc.
When was Bvf Partners L P/il's latest insider buy?
No open-market insider purchase is available for this period.
When was Bvf Partners L P/il's latest insider sale?
sale at XOMA Royalty Corp on Jan 24, 2025 valued at $3,914,348.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.